FYI from the NHLBI Index
May 2010: Vol. 11, Issue 1
Research and Resources
NHLBI Research Initiatives
- Ancillary Studies in Clinical Trials (R01)
- Atherosclerosis Risk in Communities (ARIC) Study -- Fourth Renewal (N01)
- Bioengineering Nanotechnology Initiative (STTR [R41/R42]) and (SBIR [R43/R44])
- Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases (CADET) (U50)
- Cross Organ Mechanism-Associated Phenotypes for Genetic Analyses of Heart, Lung, Blood, and Sleep Diseases (MAPGen for HLBS) (U01)
- Diet Composition and Energy Balance (R01)
- Investigator Initiated Multi-Site Clinical Trials (Collaborative R01)
- New Approaches to Arrhythmia Detection and Treatment (STTR [R41/R42])
- Next Generation Genetic Association Studies (U01)
- NHLBI Research Centers at Minority-Serving Institutions (P30)
- Planning Grants for Pivotal Clinical Trials in Hemoglobinopathies (R34)
- Renewal of the Heart, Lung, and Blood Institute Biologic Specimen Repository (N01)
Need More Information?
NHLBI Research Initiatives
From time to time, the NHLBI invites investigators to submit grant applications
or contract proposals for specific research programs. We are soliciting
applications for the new programs described below. Please visit the URL listed with each program to obtain information
about important application dates and deadlines. For full details of these and other current research initiatives,
Ancillary Studies in Clinical Trials (R01)
- Initiative Number: RFA-HL-10-024
- Objective: Conduct time-sensitive ancillary studies related to heart, lung, and blood diseases and sleep disorders
in conjunction with ongoing clinical trials and other large clinical studies.
Atherosclerosis Risk in Communities (ARIC) Study -- Fourth Renewal (N01)
- Initiative Number: NHLBI-HC-11-05
- Objective: Capitalize and expand upon the resources of data, specimens, and infrastructure developed over 25 years in the ARIC Study by re-examination
and follow-up of the aging ARIC cohort through 2016.
Bioengineering Nanotechnology Initiative (STTR [R41/R42]) and (SBIR [R43/R44])
- Initiative Number: PA-10-149/150
- Objective: Conduct small business projects that develop and apply nanotechnology to biomedicine.
Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases (CADET) (U50)
- Initiative Number: RFA-HL-11-015
- Accelerate development of novel agents for the diagnosis and treatment of lung diseases and sleep disordered breathing. The
first phase, CADET I, will involve up to 30 two-year awards to explore and validate novel targets for therapeutic or diagnostic development.
The second phase, Cadet II, beginning in FY 2013, will support development of therapeutics or diagnostics based on the most promising results
from CADET I.
Cross Organ Mechanism-Associated Phenotypes for Genetic Analyses of Heart, Lung, Blood, and Sleep Diseases (MAPGen for HLBS) (U01)
- Initiative Number: RFA-HL-11-004/005
- Objective: Define an accumulating set of mechanism-associated traits that cross organ systems based upon evolving knowledge of biological
and molecular networks with the goal of improving phenotyping of individuals for genetic research studies.
Diet Composition and Energy Balance (R01)
- Initiative Number: PA-10-152
- Objective: Investigate the role of diet composition in energy balance, in both animals and humans. Collaborations between basic
and clinical researchers are particularly encouraged.
Investigator Initiated Multi-Site Clinical Trials (Collaborative R01)
- Initiative Number: PAR-10-096
- Objective: Conduct investigator-initiated, multi-site Phase II or Phase III randomized, controlled clinical trials of biomedical or
behavioral interventions that address research questions related to the mission and goals of the NHLBI.
New Approaches to Arrhythmia Detection and Treatment (STTR [R41/R42])
- Initiative Number: PA-10-117/118
- Objective: Develop new or improved methods, tools, technologies, and approaches for the detection, treatment, and prevention of arrhythmias.
Next Generation Genetic Association Studies (U01)
- Initiative Number: RFA-HL-11-006
- Objective: Add a functional dimension to genome-wide association studies by combining cellular reprogramming strategies with molecular
profiling and by integrating this information with existing genotypic data to assess how naturally occurring human genetic variation influences
the activities of biological networks in cell-based models of disease.
NHLBI Research Centers at Minority-Serving Institutions (P30)
- Initiative Number: RFA-HL-11-019
- Objective: Augment and strengthen the research capabilities and resources related to heart, lung, blood, and sleep diseases and disorders
at existing and/or new research centers at minority-serving institutions.
Planning Grants for Pivotal Clinical Trials in Hemoglobinopathies (R34)
- Initiative Number: RFA-HL-11-009
- Objective: Plan pilot studies to answer research questions essential for the design of robust Phase II and III clinical trials in the
major hemoglobinopathies (sickle cell disease and the thalassemias).
Renewal of the Heart, Lung, and Blood Institute Biologic Specimen Repository (N01)
- Initiative Number: HB-11-19
- Objective: Maintain for an additional five years collections of biological specimens from NHLBI-sponsored epidemiological and clinical studies.
Need More Information?
We are always interested in receiving comments and suggestions from the community.
If you or your organizations have questions for me or for the Institute, please
contact me at firstname.lastname@example.org or Dr. Carl
Roth at email@example.com.
Susan B. Shurin, M.D.
Acting Director, NHLBI
For information on specific issues, the following contacts may be helpful:
For health related questions and publications,
please contact the trained information specialists
at the NHLBI Information Center
(NHLBIinfo@nhlbi.nih.gov) or write to the Information Center at P.O. Box 30105,
Bethesda, MD 20824-0105.
communications pertaining to NHLBI policies and
priorities, contact the NHLBI Office
of Public Liaison, (firstname.lastname@example.org).
additional information regarding NHLBI events, consult the references provided
or NHLBI Calendar. Most other NIH Institutes
and Centers also maintain calendars on their Web sites. Links to their Web pages
are at NIH
Institutes, Centers, and Offices.
Web related matters pertaining
to the online version of the FYI from the NHLBI, contact the FYI
from the NHLBI's Web Editor.
Please send us your feedback, comments, and questions by using the appropriate link on the page,
Contact the NHLBI.
Note to users of screen readers and other assistive technologies: please report
your problems here.
Contents | Feature
Articles | In the News | Events and Meetings | Research and Resources
All Issues | FYI Index | NHLBI Express